IP Library Granted Patent US 7,932,354
Granted Patent B2
US 7,932,354 · App. 12/399,607 · Granted Apr 26, 2011

Process for the production of collagen material

Assignee: aap Biomaterials GmbH
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,932,354
App. No.
12/399,607
Granted
Apr 26, 2011
Kind
B2
Abstract

The invention relates to a process for the production of a collagen implant for wound covering, in which a suspension comprising a telopeptide-containing collagen is produced and a phosphate buffer is added. An areal structure is produced by drying the collagen-containing mixture produced.

Claims (13)

1. A process for the production of a collagen material, comprising:

(a) producing an suspension comprising a telopeptide-containing collagen wherein said suspension has an acidic pH which has been adjusted by the addition of phosphoric acid;

(b) adding a phosphate buffer to the suspension of step (b), resulting in a telopeptide collagen-containing mixture; and

(c) drying the telopeptide collagen-containing mixture, thereby producing an areal structure.

2. The process of claim 1 , wherein a native collagen is used to produce the suspension.

3. The process of claim 1 , wherein mammalian skins are used as the collagen material.

4. The process of claim 1 , wherein the collagen-containing mixture is adjusted to a pH between 5.5 and 8.5 by addition of the phosphate buffer.

5. The process of claim 1 , wherein the suspension is produced with a collagen content of 0.3-7 wt %.

6. The process of claim 1 , wherein before drying, the mixture is adjusted to have a solids content of 0.2-10%.

7. The process of claim 1 , wherein the areal structure is produced with a disodium hydrogen phosphate component of 80-500 mg/g.

8. The process for the production of a collagen material in accordance with claim 1 , wherein the suspension of step (a) is mechanically denatured.

9. The process of claim 1 , further comprising adding an antibiotic.

10. The process of claim 3 , wherein mammalian skins from pigs are used as the collagen material.

Assignments (3)
CHANGE OF NAME Recorded Oct 23, 2018
From: AAP BIOMATERIALS GMBH
To: OSARTIS GMBH
Reel/Frame 047288/0585 →
CHANGE OF NAME Recorded Nov 5, 2010
From: AAP BIOMATERIALS GMBH & CO. KG
To: AAP BIOMATERIALS GMBH
Reel/Frame 025327/0900 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2009
From: HEIMANN, LYDIA; DINGELDEIN, ELVIRA, DR.; VOGES, MICHAEL; SCHUBERT, ELLEN
To: AAP BIOMATERIALS GMBH & CO. KG
Reel/Frame 022695/0866 →
Priority Claims (2)
DE 10 2008 013 091 · Mar 7, 2008 · national
DE 20 2008 008 627 U · Jul 1, 2008 · national
Continuity (1)
Related Publication 20090227773A1 · Sep 10, 2009